These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27027827)

  • 21. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Helicobacter pylori Eradication on the Gastrointestinal Microbiota in Patients with Duodenal Ulcer.
    Li L; Zhou X; Xiao S; Ye F; Zhang G
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):139-46. PubMed ID: 27308643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
    Zullo A; De Francesco V; Hassan C
    J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
    [No Abstract]   [Full Text] [Related]  

  • 24. Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance.
    Başyiğit S; Kefeli A; Yeniova AÖ; Uzman M; Nazlıgül Y; Aktaş B
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():293-4. PubMed ID: 25910347
    [No Abstract]   [Full Text] [Related]  

  • 25. Current pharmacotherapy options for gastritis.
    den Hollander WJ; Kuipers EJ
    Expert Opin Pharmacother; 2012 Dec; 13(18):2625-36. PubMed ID: 23167300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential therapy for H. pylori eradication.
    Drug Ther Bull; 2011 Sep; 49(9):102-5. PubMed ID: 21921072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization.
    Grosso R; Benito E; Carbajo-Gordillo AI; Díaz MJ; García-Martín MG; de-Paz MV
    Eur J Pharm Sci; 2024 Sep; 200():106840. PubMed ID: 38909691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2C19 polymorphism influences Helicobacter pylori eradication.
    Kuo CH; Lu CY; Shih HY; Liu CJ; Wu MC; Hu HM; Hsu WH; Yu FJ; Wu DC; Kuo FC
    World J Gastroenterol; 2014 Nov; 20(43):16029-36. PubMed ID: 25473155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel intervention strategies for Helicobacter pylori treatment.
    Noonan B; Alm RA
    Curr Drug Targets Infect Disord; 2002 Dec; 2(4):331-8. PubMed ID: 12570739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the Use of Vonoprazan: A Competitive Acid Blocker.
    Graham DY; Dore MP
    Gastroenterology; 2018 Feb; 154(3):462-466. PubMed ID: 29337157
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for treatment of Helicobacter pylori in the East and West.
    Selgrad M; Bornschein J; Malfertheiner P
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):581-8. PubMed ID: 21819326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori.
    Adebisi AO; Laity PR; Conway BR
    J Pharm Pharmacol; 2015 Apr; 67(4):511-24. PubMed ID: 25496042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
    Bago I; Bago J; Plečko V; Aurer A; Majstorović K; Budimir A
    J Oral Pathol Med; 2011 May; 40(5):428-32. PubMed ID: 21198868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Culture and successful eradication of Helicobacter pylori from heterotopic gastric mucosa.
    Wüppenhorst N; Viebahn B; Theile A; Radü HJ; Kist M
    Z Gastroenterol; 2012 Jul; 50(7):677-9. PubMed ID: 22760679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antibacterial effect of fatty acids on Helicobacter pylori infection.
    Jung SW; Lee SW
    Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.